Fig. 2

Allo-HSCT treatment circumvents the unfavorable outcomes of AML patients showing downregulated miR-25 expression. a, b A total of 162 cases were placed into two groups according to the median miR-25 expression levels. In the downregulated miR-25 group, the Kaplan–Meier survival curves of AML patients classified based on chemotherapy (n = 52) and allo-HSCT (n = 29) treatment. c, d In the upregulated miR-25 group, the Kaplan–Meier survival curves of AML patients classified based on chemotherapy (n = 38) and allo-HSCT (n = 43) treatment